Is hair loss really a side effect of GLP-1 medications?

Yes — a 2026 systematic review of 24 studies found semaglutide and tirzepatide had the highest reported incidence of hair loss and the most frequent signal in pharmacovigilance databases. The most common type was telogen effluvium, a temporary, diffuse shedding triggered by physiological stress, rather than permanent hair loss. The evidence points to rapid weight loss itself as the primary driver, not a direct drug effect on hair follicles.

Will my hair grow back after GLP-1 hair loss?

Telogen effluvium — the most commonly reported type — is generally temporary. Hair growth typically resumes once the body adjusts to a stable weight, though regrowth can take several months. That's a meaningful distinction from permanent patterns like androgenetic alopecia, which was also reported but less frequently.

Why is my hair shedding months after I started losing weight?

In telogen effluvium, hair follicles shift prematurely into a resting phase, and increased shedding typically shows up 2–4 months after the triggering event. So hair loss you notice today may reflect weight loss from a few months ago, not something happening right now.

Does the dose or drug matter for hair loss risk?

The review found semaglutide-related hair loss appeared dose-dependent — lower diabetes-range doses were rarely implicated, while higher weight-management doses were more commonly associated with it. Tirzepatide, which produces the greatest average weight loss, was most frequently linked to telogen effluvium, and older GLP-1 medications showed lower reported risk — consistent with a link to the magnitude of weight loss rather than the drug class broadly. Women appeared disproportionately affected.

What can I do about hair loss on a GLP-1?

Adequate protein intake and overall nutritional adequacy support healthy hair growth generally, though they won't necessarily prevent stress-related shedding entirely. If hair loss is significant or distressing, raise it with your prescriber or a dermatologist — both to confirm the type of hair loss and to discuss whether the pace of weight loss or dose adjustments are worth considering.

Hair loss on a GLP-1: what the evidence actually shows

Hair loss isn't listed on most GLP-1 drug labels, but it's a real, increasingly documented effect — particularly tied to rapid weight loss rather than the drug directly. Here's what recent research shows.

Updated Jul 18, 2026

Is hair loss actually a GLP-1 side effect?

According to PubMed, yes — a 2026 systematic review examined 24 studies on GLP-1 medications and hair loss and found semaglutide and tirzepatide had the highest reported incidence and the most frequent signal detection in pharmacovigilance databases (Gupta et al., Science Progress, 2026, DOI (external link)). The most common type reported was telogen effluvium — a temporary, diffuse hair shedding triggered by physiological stress — rather than permanent hair loss.

What the research found

Tirzepatide, associated with the greatest average weight loss among GLP-1 medications, was most frequently linked to telogen effluvium specifically — supporting the idea that rapid weight loss itself, not a direct drug effect on hair follicles, is the primary driver.
Semaglutide-related hair loss appeared dose-dependent: lower doses (under 2mg weekly, typically diabetes dosing) were rarely implicated, while higher weight-management doses were more commonly associated with hair loss.
Women appeared disproportionately affected compared to men in the reviewed studies.
Older GLP-1 medications (liraglutide, dulaglutide, exenatide) showed a lower reported risk compared to semaglutide and tirzepatide, consistent with a link to the magnitude of weight loss rather than the drug class broadly.

Why rapid weight loss causes hair shedding

Telogen effluvium is a well-documented response to significant physiological stress on the body — rapid weight loss, illness, surgery, and major caloric deficits are all known triggers, independent of GLP-1 medications specifically. Hair follicles shift prematurely into a resting phase, leading to increased shedding typically 2-4 months after the triggering event — meaning hair loss noticed today may reflect weight loss from a few months ago, not something happening right now.

hair-lossalopeciaside-effects

Was this helpful?

Common questions

Questions people often ask about this topic.

Is hair loss really a side effect of GLP-1 medications?
Yes — a 2026 systematic review of 24 studies found semaglutide and tirzepatide had the highest reported incidence of hair loss and the most frequent signal in pharmacovigilance databases. The most common type was telogen effluvium, a temporary, diffuse shedding triggered by physiological stress, rather than permanent hair loss. The evidence points to rapid weight loss itself as the primary driver, not a direct drug effect on hair follicles.
Will my hair grow back after GLP-1 hair loss?
Telogen effluvium — the most commonly reported type — is generally temporary. Hair growth typically resumes once the body adjusts to a stable weight, though regrowth can take several months. That's a meaningful distinction from permanent patterns like androgenetic alopecia, which was also reported but less frequently.
Why is my hair shedding months after I started losing weight?
In telogen effluvium, hair follicles shift prematurely into a resting phase, and increased shedding typically shows up 2–4 months after the triggering event. So hair loss you notice today may reflect weight loss from a few months ago, not something happening right now.
Does the dose or drug matter for hair loss risk?
The review found semaglutide-related hair loss appeared dose-dependent — lower diabetes-range doses were rarely implicated, while higher weight-management doses were more commonly associated with it. Tirzepatide, which produces the greatest average weight loss, was most frequently linked to telogen effluvium, and older GLP-1 medications showed lower reported risk — consistent with a link to the magnitude of weight loss rather than the drug class broadly. Women appeared disproportionately affected.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

1Supporting

GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling (external link)
Science Progress, 2026 · Peer-reviewed study
Systematic review of 24 studies finding semaglutide and tirzepatide had highest hair loss incidence, dose-dependent for semaglutide, disproportionately affecting women, primarily telogen effluvium.

Improve this page

Hair loss on a GLP-1: what the evidence actually shows

Is hair loss actually a GLP-1 side effect?

What the research found

Why rapid weight loss causes hair shedding

Common questions

Evidence: For & Against

1Supporting

What tends to happen over time

What can help

The bottom line

Related terms

Related guides